Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns

IMPORTANCE: Targeted therapies directed against ERBB2 are the cornerstone of medical treatment for ERBB2-positive breast cancers but are contraindicated during pregnancy. OBJECTIVES: To describe the association of exposure to anti-ERBB2 agents during pregnancy with pregnancy and fetal or newborn out...

Descripción completa

Detalles Bibliográficos
Autores principales: Gougis, Paul, Grandal, Beatriz, Jochum, Floriane, Bihan, Kevin, Coussy, Florence, Barraud, Solenn, Asselain, Bernard, Dumas, Elise, Sebbag, Clara, Hotton, Judicael, Spaggiari, Emmanuel, Pierga, Jean-Yves, Savarino, Raphaëlle, Laas, Enora, Spano, Jean-Philippe, Reyal, Fabien, Hamy, Anne-Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603505/
https://www.ncbi.nlm.nih.gov/pubmed/37883083
http://dx.doi.org/10.1001/jamanetworkopen.2023.39934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603505/
https://www.ncbi.nlm.nih.gov/pubmed/37883083
http://dx.doi.org/10.1001/jamanetworkopen.2023.39934

Ejemplares similares